High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype

References

• Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183–196.
   PubMed Web of Science ®Google Scholar
• Jacques C, Gosset M, Berenbaum F. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam Horm. 2006;74:371–403.
   PubMed Web of Science ®Google Scholar
• Arend WP, Guthridge CJ. Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis. 2000;59(1):i60–i64.
   Web of Science ®Google Scholar
• Dayer JM. Evidence for the biological modulation of IL-1 activity: the role of IL-1Ra. Clin Exp Rheumatol. 2002;20:S14–S20.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang F, Hu H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481–487.
   PubMed Web of Science ®Google Scholar
• Tolusso B, Pietrapertosa D, Morelli A, et al. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics. 2006;7:683–695.
   PubMed Web of Science ®Google Scholar
• Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998;28:2598–2602.
   PubMed Web of Science ®Google Scholar
• Ramírez-Pérez S, Salazar-Páramo M, Pineda-Monjarás S. Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis. Clin Rheumatol. 2017;36:1247–1252.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159.
   PubMed Web of Science ®Google Scholar
• Guzmán-Guzmán IP, Reyes-Castillo Z, Muñoz-Barrios S, et al. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population. Immunol Lett. 2015;163:214–220.
   PubMed Web of Science ®Google Scholar
• Hernández-Bello J, Oregón-Romero E, Vázquez-Villamar M, et al. Aberrant expression of interleukin-10 in rheumatoid arthritis: relationship with IL10 haplotypes and autoantibodies. Cytokine. 2017;95:88–96.
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A, Pawlik A, Romanowska-Prochnicka K, et al. Relationship between VEGF gene polymorphisms and serum VEGF protein levels in patients with rheumatoid arthritis. PLoS One. 2016;11:e0160769.
   PubMed Web of Science ®Google Scholar
• Jian-Ming C, Jing G, Chuan-Dong W, et al. The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus. BMC Genet. 2015;16:121.
   PubMed Web of Science ®Google Scholar
• Magyari L, Varszegi D, Kovesdi E, et al. Interleukins and interleukin receptors in rheumatoid arthritis: research, diagnostics and clinical implications. WJO. 2014;5:516–536.
   Google Scholar
• Buchs N, di Giovine FS, Silvestri T, et al. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2001;2:222–228.
   PubMed Web of Science ®Google Scholar
• Scuderi F, Convertino R, Molino N, et al. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity. 2003;36:71–77.
   PubMed Web of Science ®Google Scholar
• Malyak M, Guthridge JM, Hance KR, et al. Characterization of a low molecular weight isoform of IL-1 receptor antagonist. J Immunol. 1998;161:1997–2003.
   PubMed Web of Science ®Google Scholar
• Malyak M, Smith MF, Jr, Abel AA, et al. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes. J Immunol. 1998;161:2004–2010.
   PubMed Web of Science ®Google Scholar
• Palmer G, Guerne PA, Mezin F, et al. Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Res. 2002;4:226–231.
   PubMedGoogle Scholar
• Maret M, Chicheportiche R, Dayer JM, et al. Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts. Cytokine. 2004;25:193–203.
   PubMed Web of Science ®Google Scholar
• Cutolo M. Effects of DMARDs on IL-1Ra levels in rheumatoid arthritis: is there any evidence? Clin Exp Rheumatol. 2002;20:S26–S31.
   PubMed Web of Science ®Google Scholar
• Vamvakopoulos J, Green C, Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol. 2002;32:2988–2996.
   PubMed Web of Science ®Google Scholar
• Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol. 2009;10:741–754.
   PubMed Web of Science ®Google Scholar
• Nishimoto N. Cytokine signal regulation and autoimmune disorders. Autoimmunity. 2005;38:359–367.
   PubMed Web of Science ®Google Scholar
• Horwood N. Lymphocyte-derived cytokines in inflammatory arthritis. Autoimmunity. 2008;41:230–238.
   PubMed Web of Science ®Google Scholar
• Hu SHK, Mitcho YL, Oronsky AL, et al. Studies on the effect of methotrexate on macrophage function. J Rheumatol. 1988;15:206–209.
   PubMed Web of Science ®Google Scholar
• Connolly KM, Stecher VJ, Danis E, et al. Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate. Int J Immunopharmacol. 1988;10:717–728.
   PubMed Web of Science ®Google Scholar
• Brody M, Bohm I, Bauer R. Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin-1 beta to the interleukin-1 receptor on target cells. Eur J Chem Clin Biochem. 1993;31:667–674.
   PubMedGoogle Scholar
• Cutolo M, Bisso A, Sulli A, et al. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from rheumatoid arthritis patients. J Rheumatol. 2000;27:2551–2557.
   PubMed Web of Science ®Google Scholar
• van den Borne BE, Dijkmans BA, de Rooij HH, et al. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol. 1997;24:55–60.
   PubMed Web of Science ®Google Scholar
• Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995; 270:286–290.
   PubMed Web of Science ®Google Scholar
• Arzt E, Sauer J, Pollmächer T, et al. Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology. 1994;134:672–677.
   PubMed Web of Science ®Google Scholar
• Clinchy B, Gunnerås M, Håkansson A, et al. Production of IL-1Ra by human mononuclear blood cells in vitro: influence of serum factors. Cytokine. 2006;34:320–330.
   PubMed Web of Science ®Google Scholar
• Liou LB. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol. 2001;19:515–523.
   PubMed Web of Science ®Google Scholar